Annals of Tropical Medicine and Public Health
Home About us Ahead Of Print Instructions Submission Subscribe Advertise Contact e-Alerts Editorial Board Login 
Users Online:171
  Print this page  Email this page Small font sizeDefault font sizeIncrease font size

Table of Contents   
Year : 2015  |  Volume : 8  |  Issue : 4  |  Page : 144-145
Epidemiology of hepatitis C viral infection

Department of Microbiology, Prathima Institute of Medical Sciences, Karimnagar, Telangana, India

Click here for correspondence address and email

Date of Web Publication7-Aug-2015

How to cite this article:
Kandi V. Epidemiology of hepatitis C viral infection. Ann Trop Med Public Health 2015;8:144-5

How to cite this URL:
Kandi V. Epidemiology of hepatitis C viral infection. Ann Trop Med Public Health [serial online] 2015 [cited 2021 Apr 14];8:144-5. Available from:
Dear Sir,

The Review paper published by Chigurupati et al. [1] has discussed the incidence of hepatitis C viral infection among hemodialysis patients. The study results reveal an infection rate of 23% among the patients undergoing hemodialysis. Hepatitis C virus (HCV) infection is a blood-borne viral infection belonging to the RNA group of viruses that are spherical, enveloped, measure around 50 nm, possess a positive (+) sense single-stranded RNA as their nucleic acid, and belong to the Flaviviridae family and the genus Hepacivirus. HCV is primarily transmitted through parenteral route (exposure to blood and blood products), blood transfusion, intravenous drug use (IDU), and vertical route (from mother to child). Although less efficient, other modes of HCV transmission include occupational exposure, unsafe sexual contact, tattooing, and body piercing as in acupuncture. Household exposure resulting in percutaneous or mucous membrane exposure to infected blood (sharing razors/shrapnels and toothbrush) can also transmit HCV. [2] Global prevalence of HCV varies geographically, and the prevalence rates among the high-risk group differ from that of the general population. Most of the studies in India have stated that there was more than 20% prevalence among the patients undergoing hemodialysis, as in the case of the current study. Although India has a very low prevalence of both hepatitis B virus (HBV) (3.7%) and HCV (<2%) as compared to other developing countries, the cause of concern is the lack of reliable data on the epidemiology of HCV infection. [3],[4] A recent study that was conducted by me and my colleagues on the patients attending a tertiary care hospital (Prathima Institute of Medical Sciences Hospital) has revealed a low prevalence rate of HCV (0.04%) as compared to HBV (1.8%) and human immunodeficiency virus (HIV) (1.5%). [5]

The availability of a vaccine and inclusion of the vaccine in immunization programs in India and many other countries may lower the incidence of HBV in the future, but the cause of concern is the nonavailability of a vaccine against HCV. Although HCV prevalence rates are lower in the general population, the infection rates are significantly high in the risk groups. Considering the fact that HCV appears in different genotypes, studies in the future must be encouraged to find the prevalent genotype and the specific genotype found in particular groups of population. As there is no available vaccine recommended against HCV, prevention of HCV transmission remains a mainstay in reducing newer infections. As HCV infection initiates both hepatic and extrahepatic inflammation and since antiviral therapy against HCV may lead to toxic side effects, studies must be encouraged on pretherapeutic assessment and continuous and regular monitoring of the patients on treatment. Identification of comorbidities (coinfection with HBV, HIV, alcoholism, and extreme age) can help in reducing the morbidity and mortality associated with HCV infection. Epidemiological studies on the prevalence of HCV infection and distribution of genotypes in various geographical regions, and planning and implementation of specific guidelines in the diagnosis of acute and chronic HCV infection is the need of the hour.

   References Top

Chigurupati P, Subbarayudu S, Babu S. Study of incidence of hepatitis C virus infection in hemodialysis patients. J NTR Univ Health Sci 2014;3:19-22.  Back to cited text no. 1
  Medknow Journal  
Ramana KV. Viral hepatitis: An insight in to chronic liver disease caused by hepatitis C virus (HCV). J Med Microb Diagn 2013;2:e117.   Back to cited text no. 2
Hwang EW, Cheung R. Global epidemiology of hepatitis B virus (HBV) infection. N A J Med Sci 2011;4:7-13.  Back to cited text no. 3
Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect 2011;17:107-15.  Back to cited text no. 4
Ramana KV, Reddy GS, Rao SD, Kalaskar A. Seroprevalence of blood-borne viral infections in post HAART era at a tertiary care hospital in South India: A five year trend analysis (2008-2012) and a comprehensive review. Br J Med Med Res 2013;3:1929-37.  Back to cited text no. 5

Correspondence Address:
Venkataramana Kandi
Department of Microbiology, Prathima Institute of Medical Sciences, Karimnagar, Telangana
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/1755-6783.162401

Rights and Permissions


    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Email Alert *
    Add to My List *


 Article Access Statistics
    PDF Downloaded14    
    Comments [Add]    

Recommend this journal